TABLE 3.
Antiserum (0.1-ml dose) | Day(s) of antiserum administration | No. of mice infected for serum dilution of:
|
ED50 | |||
---|---|---|---|---|---|---|
None (undiluted) | 1:5 | 1:25 | 1:125 | |||
Pre-DbpA297 | 0 | 0/3 | 1/3 | 2/3 | 3/3 | 1:11.2 |
0, 2 | 0/3 | 0/3 | 0/3 | 2/3 | 1:83.1 | |
OspAB31 | 0 | 0/3 | 1/3 | 3/3 | NDa | 1:7.5 |
0, 2 | 0/3 | 1/3 | 3/3 | ND | 1:7.5 |
ND, not determined.